Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. [electronic resource]
Producer: 19971015Description: 843-9 p. digitalISSN:- 0012-186X
- C-Peptide -- blood
- Cholesterol -- blood
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Estradiol -- therapeutic use
- Estrogen Replacement Therapy
- Fatty Acids, Nonesterified -- blood
- Female
- Fibrinolysis -- drug effects
- Glycated Hemoglobin -- analysis
- Humans
- Insulin Resistance
- Lipids -- blood
- Lipoproteins -- blood
- Middle Aged
- Plasminogen Activator Inhibitor 1 -- blood
- Postmenopause
- Tissue Plasminogen Activator -- blood
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.